Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Nasdaq Real Time Price USD

Entero Therapeutics, Inc. (ENTO)

Compare
0.4101
-0.0700
(-14.58%)
At close: April 1 at 4:00:00 PM EDT
0.4420
+0.03
+(7.78%)
After hours: April 1 at 6:16:19 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
18,511.3840
15,770.8270
12,678.0660
56,704.9000
26,432.7680
Operating Income
-18,511.3840
-15,770.8270
-12,678.0660
-56,704.9000
-26,432.7680
Net Non Operating Interest Income Expense
-6.1490
-19.9320
-7.4640
-10.0620
-5,840.1300
Other Income Expense
-8.3540
-4.2240
-1,944.1120
-1,822.8870
-398.5680
Pretax Income
-18,525.8870
-15,794.9830
-14,629.6420
-58,537.8490
-32,671.4660
Net Income Common Stockholders
-10,149.8640
-16,103.1110
-14,973.0690
-84,518.5880
-41,732.3380
Diluted NI Available to Com Stockholders
-10,149.8640
-16,103.1110
-14,973.0690
-84,518.5880
-41,732.3380
Basic EPS
13.50
-47.88
-416.94
-39.77k
-56.32k
Diluted EPS
13.50
-47.88
-416.94
-39.77k
-56.32k
Basic Average Shares
2,449.0020
336.3420
35.9120
2.1250
0.7410
Diluted Average Shares
2,449.0020
336.3420
35.9120
2.1250
0.7410
Total Operating Income as Reported
-18,511.3840
-15,770.8270
-12,678.0660
-59,056.8880
-26,432.7680
Total Expenses
18,511.3840
15,770.8270
12,678.0660
56,704.9000
26,432.7680
Net Income from Continuing & Discontinued Operation
-9,922.0070
-15,794.9830
-14,629.6420
-58,537.8490
-32,671.4660
Normalized Income
-7,921.2470
-15,794.9830
-12,918.2710
-56,185.8610
-32,061.4680
Interest Income
--
2.5310
8.4150
1.1730
0.4840
Interest Expense
--
22.4630
15.8790
11.2350
5,840.6140
Net Interest Income
-6.1490
-19.9320
-7.4640
-10.0620
-5,840.1300
EBIT
-18,513.0770
-15,772.5200
-14,613.7630
-58,526.6140
-26,830.8520
EBITDA
-18,456.8120
-15,743.2460
-14,584.4920
-57,984.3590
-26,265.5070
Reconciled Depreciation
56.2650
29.2740
29.2710
542.2550
565.3450
Net Income from Continuing Operation Net Minority Interest
-7,921.2470
-15,794.9830
-14,629.6420
-58,537.8490
-32,671.4660
Total Unusual Items Excluding Goodwill
--
--
-1,711.3710
-2,351.9880
-609.9980
Total Unusual Items
--
--
-1,711.3710
-2,351.9880
-609.9980
Normalized EBITDA
-18,456.8120
-15,743.2460
-12,873.1210
-55,632.3710
-25,655.5090
12/31/2020 - 10/11/2016

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

TNFA TNF Pharmaceuticals, Inc.
0.4419
+26.26%
 
PASG Passage Bio, Inc.
0.3860
+9.32%
 
ERNA Ernexa Therapeutics Inc.
0.1849
+3.88%
 
PBM Psyence Biomedical Ltd.
0.5921
-1.32%
 
PALI Palisade Bio, Inc.
0.6698
-1.62%
 
OGEN Oragenics, Inc.
0.2123
+1.10%
 
VINC Vincerx Pharma, Inc.
0.5750
+8.61%
 
SPRC SciSparc Ltd.
0.2809
-5.74%
 
SXTP 60 Degrees Pharmaceuticals, Inc.
1.8900
+5.00%
 
CMMB Chemomab Therapeutics Ltd.
1.0400
-4.59%